Latest News

STAT Plus: Pfizer says efficacy of its Duchenne gene therapy outweighs side effects

Pfizer’s experimental gene therapy to treat Duchenne muscular dystrophy appeared to improve muscle function in a study of nine boys, but also resulted in serious drug reactions in three of those children, the company said Friday.

The data are being presented at a virtual session of the American Society of Gene & Cell Therapy.

Continue to STAT Plus to read the full story…

Source link

Related posts

FDA: montelukast tablet bottles recalled


Telemedicine has undergone a series of changes from #telemedicine systems which …


AVEO Announces Proposed Offering of Common Stock


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World